BTS
BIIB icon

BB&T Securities’s Biogen BIIB Stock Holding History

BB&T Securities’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$2.95M Sell
12,677
-1,916
-13% -$446K 0.03% 487
2019
Q2 		$3.41M Sell
14,593
-1,667
-10% -$385K 0.03% 458
2019
Q1 		$3.84M Buy
16,260
+3,381
+26% +$1.06M 0.04% 430
2018
Q4 		$3.88M Sell
12,879
-316
-2% -$101K 0.04% 406
2018
Q3 		$4.66M Sell
13,195
-1,233
-9% -$425K 0.05% 409
2018
Q2 		$4.19M Buy
14,428
+1,254
+10% +$353K 0.04% 416
2018
Q1 		$3.61M Sell
13,174
-678
-5% -$210K 0.04% 445
2017
Q4 		$4.41M Buy
13,852
+65
+0.5% +$20.9K 0.06% 357
2017
Q3 		$4.32M Buy
13,787
+798
+6% +$236K 0.06% 362
2017
Q2 		$3.52M Buy
12,989
+2,598
+25% +$687K 0.05% 387
2017
Q1 		$2.84M Buy
10,391
+1,702
+20% +$481K 0.04% 394
2016
Q4 		$2.72M Hold
8,689
– – 0.04% 368
2016
Q3 		$2.72M Sell
8,689
-2,775
-24% -$822K 0.04% 368
2016
Q2 		$2.77M Sell
11,464
-169
-1% -$44.5K 0.04% 363
2016
Q1 		$3.03M Buy
11,633
+289
+3% +$76.3K 0.05% 323
2015
Q4 		$3.48M Buy
11,344
+5,103
+82% +$1.47M 0.07% 250
2015
Q3 		$1.82M Buy
6,241
+1,766
+39% +$583K 0.04% 365
2015
Q2 		$1.81M Buy
4,475
+150
+3% +$60.2K 0.04% 371
2015
Q1 		$1.83M Buy
4,325
+929
+27% +$366K 0.04% 361
2014
Q4 		$1.15M Buy
3,396
+887
+35% +$287K 0.03% 469
2014
Q3 		$830K Buy
2,509
+289
+13% +$95.3K 0.02% 523
2014
Q2 		$700K Buy
2,220
+605
+37% +$182K 0.02% 568
2014
Q1 		$494K Buy
1,615
+196
+14% +$62.2K 0.01% 600
2013
Q4 		$397K Buy
1,419
+229
+19% +$59.2K 0.01% 638
2013
Q3 		$287K Buy
1,190
+195
+20% +$43.6K 0.01% 671
2013
Q2 		$214K Buy
+995
New +$213K 0.01% 724

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BB&T Securities's BIIB Position: Q3 2019 in Review

BB&T Securities reduced its Biogen (BIIB) stake by 13% in Q3 2019, selling an estimated $446K and leaving 12,677 shares worth $2.95M. The position accounts for 0.03% of the portfolio, ranked #487.

BB&T Securities first reported a position in BIIB in Q2 2013 and has held it in 26 quarters since. The position peaked at $4.66M in Q3 2018. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • BB&T Securities held 12,677 shares of Biogen worth $2.95M as of Q3 2019.
  • BB&T Securities sold 1,916 Biogen shares in Q3 2019, an estimated $446K.
  • Biogen made up 0.03% of BB&T Securities's portfolio in Q3 2019, its #487 holding.
  • BB&T Securities first reported a position in Biogen in Q2 2013 and has held it in 26 quarters since.
  • BB&T Securities's Biogen position peaked at $4.66M in Q3 2018.
  • 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.